Search

everythinglearnresearchcommunity

for

Search:↓

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

New compounds show promise as nonsteroidal treatments for hair loss.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The development of breeding tubercles in male zebrafish relies on a specific enzyme that processes hormones.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Finasteride improves hair loss in women with hyperandrogenism.

Finasteride may improve stem cell therapy for heart attacks by increasing cell survival.

Testosterone helps human pancreatic cells increase insulin release.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Finasteride may increase depression by reducing brain cell growth.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Jute leaves may help reduce DHT levels, potentially aiding in conditions like hair loss and prostate issues.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.